{"database": "openregs", "table": "documents", "rows": [["FDA-2008-D-0610-0009", "FDA", "FDA-2008-D-0610", "Guidance for Industry Postmarketing Adverse Event Reporting for Medical Products and Dietary Supplements During an Influenza Pandemic", "Other", "GDL-Guidance (Supporting and Related Materials)", "2011-01-10T05:00:00Z", 2011, 1, "2011-01-10T05:00:00Z", "2011-03-09T04:59:59Z", "2020-03-19T19:31:38Z", null, 0, 0, "0900006480bc6e66"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2008-D-0610-0009"], "units": {}, "query_ms": 5.74492709711194, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}